- Report
- March 2025
- 200 Pages
Global
From €4269EUR$4,490USD£3,590GBP
- Report
- May 2021
- 50 Pages
China
From €2472EUR$2,600USD£2,079GBP
- Report
- July 2023
- 95 Pages
Global
From €3500EUR$3,943USD£3,046GBP
Paclitaxel Injection is a chemotherapy drug used to treat breast cancer. It is a semi-synthetic derivative of the natural product Taxol, which is extracted from the bark of the Pacific yew tree. Paclitaxel Injection works by interfering with the growth of cancer cells, preventing them from dividing and spreading. It is usually administered intravenously, and is often used in combination with other drugs to treat advanced stages of breast cancer. Common side effects of Paclitaxel Injection include hair loss, nausea, vomiting, and fatigue.
The Paclitaxel Injection market is a highly competitive one, with many companies offering their own versions of the drug. Some of the major players in the market include Bristol-Myers Squibb, Pfizer, Teva Pharmaceuticals, and Mylan. Other companies such as Hospira, Sun Pharmaceuticals, and Dr. Reddy's Laboratories also offer Paclitaxel Injection. Show Less Read more